Suppr超能文献

非洲裔人群青光眼及相关疾病研究(ADAGES)中的青光眼视野进展:十一年随访。

Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES): Eleven Years of Follow-up.

机构信息

From the Bernard and Shirlee Brown Glaucoma Research Laboratory (B.M., I.A.V., G.D.M., G.A.C., J.M.L.), Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, USA; Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery (B.M., J.S.P.), Ribeirao Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

From the Bernard and Shirlee Brown Glaucoma Research Laboratory (B.M., I.A.V., G.D.M., G.A.C., J.M.L.), Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, USA.

出版信息

Am J Ophthalmol. 2022 Jul;239:122-129. doi: 10.1016/j.ajo.2022.02.003. Epub 2022 Feb 13.

Abstract

PURPOSE

To compare the rates of visual field (VF) progression between individuals of Black and White race and to investigate whether treatment effects may help explain differences previously reported between racial groups.

DESIGN

Multicenter prospective observational cohort study.

METHODS

Participants were patients in referral tertiary care glaucoma clinics with open angle glaucoma. Eyes were excluded who had <5 VF tests and <2 years of follow-up or any disease that could affect the optic nerve or the VF. The VF mean deviation (MD) slopes over time (dB/y) were calculated with linear regression models. Socioeconomic variables, rates of glaucoma surgery, medications, treated intraocular pressure (IOP), and central corneal thickness (CCT) were investigated.

RESULTS

A total of 516 eyes were included with a mean (95% CI) follow-up time of 11.0 (range, 10.5-11.5) years and 15.0 (range, 14.1-15.8) visits. Participants of Black race were significantly younger (59.7 vs 66.9 years, P < .01) than those of White race. The mean CCT and socioeconomic variables were similar between Black and White groups (P = 0.20 and P = .56, respectively), as were treatment with topical medications (P = .90) and the rate of VF MD change (-0.24 [-0.31 to -0.17] dB/year vs -0.32 [-0.36 to -0.27], P = .11), despite higher treated mean IOP (14.9 [14.5 to 15.4] vs 14.0 [13.6 to 14.4] mm Hg, P = .03) and fewer trabeculectomies (29.5% vs 50.0%, P < .01) in the Black race group.

CONCLUSIONS

Rates of VF progression were similar despite higher treated IOP in the Black race group. Mitigation of health access disparities in this study may have equalized previously reported different rates of VF progression between racial groups.

摘要

目的

比较黑人和白人种族个体之间视野(VF)进展的速度,并探讨治疗效果是否有助于解释先前报告的不同种族群体之间的差异。

设计

多中心前瞻性观察队列研究。

方法

参与者为具有开角型青光眼的转诊三级护理青光眼诊所的患者。排除具有<5 次 VF 测试和<2 年随访或任何可能影响视神经或 VF 的疾病的眼睛。使用线性回归模型计算随时间推移的 VF 平均偏差(MD)斜率(dB/y)。研究了社会经济变量、青光眼手术率、药物、治疗眼内压(IOP)和中央角膜厚度(CCT)。

结果

共纳入 516 只眼,平均(95%CI)随访时间为 11.0 年(范围,10.5-11.5 年)和 15.0 次就诊(范围,14.1-15.8 年)。黑人种族的参与者明显比白人种族的参与者年轻(59.7 岁 vs 66.9 岁,P<.01)。黑人组和白人组的平均 CCT 和社会经济变量相似(P=.20 和 P=.56),局部药物治疗(P=.90)和 VF MD 变化率(-0.24 [-0.31 至 -0.17] dB/年 vs -0.32 [-0.36 至 -0.27],P=.11)也相似,尽管黑人组的治疗平均 IOP 较高(14.9 [14.5 至 15.4] vs 14.0 [13.6 至 14.4] mm Hg,P=.03)和更少的小梁切除术(29.5% vs 50.0%,P<.01)。

结论

尽管黑人组的治疗 IOP 较高,但 VF 进展的速度相似。在这项研究中,缓解健康获取方面的差异可能使先前报告的不同种族群体之间的 VF 进展率趋于一致。

相似文献

6
The Effect of Achieving Target Intraocular Pressure on Visual Field Worsening.目标眼压达标对视野恶化的影响。
Ophthalmology. 2022 Jan;129(1):35-44. doi: 10.1016/j.ophtha.2021.08.025. Epub 2021 Sep 8.
7
Impact of Smoking on Visual Field Progression in a Long-term Clinical Follow-up.吸烟对长期临床随访中视野进展的影响。
Ophthalmology. 2022 Nov;129(11):1235-1244. doi: 10.1016/j.ophtha.2022.06.017. Epub 2022 Jun 23.
9
Risk Factors for Fast Visual Field Progression in Glaucoma.青光眼视野快速进展的危险因素。
Am J Ophthalmol. 2019 Nov;207:268-278. doi: 10.1016/j.ajo.2019.06.019. Epub 2019 Jun 22.

引用本文的文献

5
Social determinants of health and health disparities in glaucoma: A review.社会决定因素与青光眼健康差异:综述。
Clin Exp Ophthalmol. 2024 Apr;52(3):276-293. doi: 10.1111/ceo.14367. Epub 2024 Feb 22.
6
Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study.药物治疗眼高压研究中的风险计算。
Ophthalmol Glaucoma. 2023 Nov-Dec;6(6):592-598. doi: 10.1016/j.ogla.2023.06.005. Epub 2023 Jun 17.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验